Clincosm LogoSign in Get a demo

hepatitis c virus (hcv)

Showing 1 - 20 of 20
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Maviret in Adolescent Chronic Hepatitis C Virus

Recruiting
  • Hepatitis C Virus (HCV)
    • Kariya-shi, Aichi, Japan
    • +34 more
    Oct 27, 2022

    Hepatitis C Virus (HCV) Trial in Worldwide (Glecaprevir/pibrentasvir adult formulation, Glecaprevir/pibrentasvir pediatric

    Completed
    Has Results
    • Hepatitis C Virus (HCV)
    • Glecaprevir/pibrentasvir adult formulation
    • Glecaprevir/pibrentasvir pediatric formulation
    • San Francisco, California
    • +37 more
    Sep 19, 2022

    Hepatitis C Virus (HCV) Trial in Worldwide (Glecaprevir/Pibrentasvir (GLE/PIB))

    Recruiting
    • Hepatitis C Virus (HCV)
    • Glecaprevir/Pibrentasvir (GLE/PIB)
    • Chandler, Arizona
    • +62 more
    Aug 8, 2022

    Glecaprevir/Pibrentasvir in Chronic Hepatitis C Genotypes 1 to 6

    Completed
    • Hepatitis C Virus (HCV)
      • Makhachkala, Dagestan, Respublika, Russian Federation
      • +7 more
      Jun 23, 2022

      Oral Glecaprevir/Pibrentasvir Tablet In Pediatric And Adult

      Completed
      • Hepatitis C Virus (HCV)
        • Chelyabinsk, Russian Federation
        • +5 more
        Jun 8, 2022

        Oral Glecaprevir/Pibrentasvir Tablets in Participants Aged 12

        Active, not recruiting
        • Hepatitis C Virus (HCV)
          • Chelyabinsk, Russian Federation
          • +9 more
          Mar 1, 2022

          Hepatitis C Virus (HCV) Trial in Worldwide (Glecaprevir/Pibrentasvir)

          Completed
          Has Results
          • Hepatitis C Virus (HCV)
          • San Diego, California
          • +24 more
          Jul 14, 2021

          Viekira/Exviera for Korean Hepatitis C Patients According to

          Completed
          • Hepatitis C Virus (HCV)
            • Busan, Busan Gwang Yeogsi, Korea, Republic of
            • +58 more
            Oct 6, 2020

            Hepatitis C Virus (HCV) Trial in Worldwide (Glecaprevir/Pibrentasvir)

            Completed
            Has Results
            • Hepatitis C Virus (HCV)
            • Phoenix, Arizona
            • +112 more
            Jun 24, 2020

            Hepatitis C Virus (HCV) Trial in Brazil (Glecaprevir/Pibrentasvir)

            Completed
            Has Results
            • Hepatitis C Virus (HCV)
            • Vitoria, Espirito Santo, Brazil
            • +13 more
            Mar 4, 2020

            Hepatitis C Virus (HCV) Trial in China, Korea, Republic of, Singapore (Placebo, Glecaprevir/Pibrentasvir)

            Completed
            Has Results
            • Hepatitis C Virus (HCV)
            • Beijing, Beijing, China
            • +47 more
            Dec 5, 2019

            Hepatitis C Virus (HCV) Trial (ombitasvir/paritaprevir/ritonavir and dasabuvir, ribavirin)

            Completed
            Has Results
            • Hepatitis C Virus (HCV)
            • ombitasvir/paritaprevir/ritonavir and dasabuvir
            • ribavirin
            • (no location specified)
            Nov 27, 2019

            Hepatitis C Virus (HCV) Trial in China, Korea, Republic of (Glecaprevir/Pibrentasvir)

            Completed
            Has Results
            • Hepatitis C Virus (HCV)
            • Beijing, Beijing, China
            • +33 more
            Nov 4, 2019

            Hepatitis C Virus (HCV) Trial in Worldwide (Glecaprevir/Pibrentasvir)

            Completed
            Has Results
            • Hepatitis C Virus (HCV)
            • Birmingham, Alabama
            • +41 more
            Aug 12, 2019

            Hepatitis C Virus (HCV) Trial in Worldwide (Glecaprevir/pibrentasvir)

            Completed
            Has Results
            • Hepatitis C Virus (HCV)
            • La Jolla, California
            • +37 more
            Feb 6, 2019

            Hepatitis C Virus (HCV) Trial (ombitasvir/paritaprevir/ritonavir and dasabuvir, ombitasvir/paritaprevir/ritonavir)

            Completed
            Has Results
            • Hepatitis C Virus (HCV)
            • (no location specified)
            Oct 31, 2017

            Hepatitis C Virus (HCV) Trial (ombitasvir/paritaprevir/ritonavir and dasabuvir, Placebo for ombitasvir/paritaprevir/ritonavir

            Completed
            Has Results
            • Hepatitis C Virus (HCV)
            • ombitasvir/paritaprevir/ritonavir and dasabuvir
            • Placebo for ombitasvir/paritaprevir/ritonavir and dasabuvir
            • (no location specified)
            Sep 29, 2017

            Hepatitis C Virus (HCV) Trial in Worldwide (Pegylated interferon lambda (pegIFN?), Pegylated interferon alfa-2a (pegIFNa-2a),

            Completed
            • Hepatitis C Virus (HCV)
            • Pegylated interferon lambda (pegIFNλ)
            • +4 more
            • Phoenix, Arizona
            • +123 more
            Sep 23, 2015

            Hepatitis C Virus (HCV) Trial in Czech Republic, Korea, Republic of, Mexico (Peginterferon Lambda-1a, Ribavirin, Peginterferon

            Completed
            • Hepatitis C Virus (HCV)
            • Peginterferon Lambda-1a
            • +2 more
            • Hradec Kralove, Czech Republic
            • +15 more
            Jan 27, 2015

            Hepatitis C Virus (HCV) Trial in Worldwide (Pegylated Interferon Lambda, Pegylated Interferon Alfa-2a, Ribavirin)

            Withdrawn
            • Hepatitis C Virus (HCV)
            • Pegylated Interferon Lambda
            • +2 more
            • San Diego, California
            • +99 more
            Feb 2, 2012